Featured

Natalie Yeadon

Top 10 Tips for Running a Successful Virtual Event

The ways that pharmaceutical and scientific communities attend meetings and events completely changed in 2020. Virtual events are rapidly improving, as are the platforms...

Natalie Yeadon - March 25, 2021

Natalie Yeadon

The Zeigarnik Effect – What is it and how can it help increase productivity?

As I discussed in my recent webinar on the power of habit, habits, whether conscious or subconscious, are the cause of about 40-45% of...

Natalie Yeadon - January 7, 2020

Santen and UBE Received FDA Approval for OMLONTI® (Omidenepag Isopropyl Ophthalmic Solution) 0.002% for the Reduction of Elevated Intraocular Pressure in Patients with Primary...

Regulatory Affairs September 27, 2022

Acticor Biotech Announces the Enrollment of the First US Patient in its Phase 2/3 Study ACTISAVE for the Treatment of Stroke

Industry News September 27, 2022

Ocular Therapeutix™ Announces Interim 7-month Data from U.S. Phase 1 Clinical Trial of OTX-TKI for the Treatment of Wet AMD

Industry News September 27, 2022

DEM BioPharma Establishes Leadership Team with Appointment of Nenad Grmusa as CEO and Christophe Quéva, Ph.D., as CSO

Regulatory Affairs September 27, 2022

Bio-Thera Solutions Announces Enrollment Completed in Phase 1 Study for BAT2022, a Broadly Potent Neutralizing Bi-specific Antibody Against SARS-CoV-2

Industry News September 27, 2022

Aura Biosciences to Present Ongoing Phase 2 Data Evaluating Suprachoroidal Administration of Belzupacap Sarotalocan (AU-011) for the First-Line Treatment of Patients with Early-Stage Choroidal...

Industry News September 27, 2022

AmerisourceBergen Elects Lorence H. Kim, M.D., to Its Board of Directors

Look Who’s On the Move! September 27, 2022

Aktana Welcomes New Medical Affairs Lead from IBM Watson Health (Now Merative)

Editor´s Pick September 27, 2022

Blue Earth Diagnostics Announces FDA Acceptance of New Drug Application for 18F-rhPSMA-7.3, a Radiohybrid Prostate-Specific Membrane Antigen-Targeted PET Imaging Agent for Prostate Cancer

Regulatory Affairs September 27, 2022

Partnering with Patients and Caregivers in Clinical Research

Natalie Yeadon September 26, 2022

Ferring Receives Positive Vote from U.S. FDA Advisory Committee for RBX2660

Regulatory Affairs September 23, 2022

AlivaMab Discovery Services Reappoints Dr. Larry Green as Chief Executive Officer

Look Who’s On the Move! September 23, 2022

Janux Therapeutics Appoints Brenda Van Vreeswyk as Head of Human Resources

Look Who’s On the Move! September 23, 2022

Alnylam Announces New Management Appointments

Industry News September 22, 2022

Janux Therapeutics Appoints Winston Kung to Board of Directors

Look Who’s On the Move! September 22, 2022

Featured

Recent Articles